Back to Search
FARRELL MENDELSOHN, MD
MD
Cardiovascular Disease Physician
NPI: 1770548307IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
21745(AL)
CMS Specialties
PrimaryCARDIOVASCULAR DISEASE (CARDIOLOGY)
Additional
PERIPHERAL VASCULAR DISEASE
Education
JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE
Class of 1992
Research & Publications (20)
Hyperperfusion syndrome following carotid artery stenting: the largest single-operator series to date.
PMID 19126924·J Invasive Cardiol·2009
8-other
Identification and characterization of a new cognitive enhancer based on inhibition of insulin-regulated aminopeptidase.
PMID 18716029·FASEB J·2008
7-preclinical
Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia.
PMID 18559703·Circulation·2008
2-rct
Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease.
PMID 17452167·Am Heart J·2007
3-trial
Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment.
PMID 16791287·Gene Ther·2006
3-trial
Oxytocinase/insulin-regulated aminopeptidase is distributed throughout the sheep, female reproductive tract and is regulated by oestrogen in the uterus.
PMID 15380925·Regul Pept·2004
7-preclinical
Attenuation of scopolamine-induced learning deficits by LVV-hemorphin-7 in rats in the passive avoidance and water maze paradigms.
PMID 15302130·Behav Brain Res·2004
4-observational
Design of the Del-1 for therapeutic angiogenesis trial (DELTA-1), a phase II multicenter, double-blind, placebo-controlled trial of VLTS-589 in subjects with intermittent claudication secondary to peripheral arterial disease.
PMID 15212720·Hum Gene Ther·2004
3-trial
Effect of I.C.V. injection of AT4 receptor ligands, NLE1-angiotensin IV and LVV-hemorphin 7, on spatial learning in rats.
PMID 14980384·Neuroscience·2004
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 801 PRINCETON AVE SW, SUITE 707
BIRMINGHAM, AL 35211 - Phone
- (205) 780-4330
Quick Facts
- NPI
- 1770548307
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 34
- Publications
- 20
Are you this provider?
Claim Your Profile